MENU
IMCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Immunocore Holdings (IMCR) Ownership - Who owns Immunocore Holdings?
Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more
Profile
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.72B
P/E Ratio
N/A
Total Cash
882.81M
Projected Growth
N/A
Total Debt
436.46M
Revenue
356.15M
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash/Share
17.52
Total Debt/Equity
N/A
Revenue/Share
7.11 USD as % of share price
Fundamentals
IMCR
Capitalization
1.72B
P/E Ratio
N/A
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash
883M
Total Cash/Share
17.52
Total Debt
436M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.11%
Revenue
356M
ROE
N/A
Book Value
388M
P/B Ratio
4.42
Cash Flow
N/A
Earnings
-0.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
135K
Current Ratio
5.89
Current Revenue Per Employee
198709.94
Dividends Per Share - Security
N/A
EBITDA
-1.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.94
Revenue To Assets
-1.93
Shares Held By Institutions
2.13B
Shares Outstanding - Current
50.4M
Total Liabilities
694M
Total Volume MTD
N/A
Value
N/A
Gain YTD
15.525
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMCR showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
92 Park Drive
Phone
+44 1235438600
Employees
497
Web
https://www.immunocore.com